HSCLBSEHIMADRI SPECIALITY CHEM LMediumNeutral
Announced Tue, 21 Jul · 19:30 IST

Q1FY27 Earnings Call: 28% Revenue Growth, 2 New Products, INR 2,000 Cr Capex

Analyst Day Multiyear TargetsCfo Debt Reduction RoadmapMgmt Guided Margin ImprovementMgmt Evaded Key QuestionInvestor Communications View source PDF

HSCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.9%1-day move
₹799.25
prior close
₹819.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-2.2-2.2-1.2-2.9-1.4-1.1
Up moveDown movePending
AI summary

Q1FY27 revenue grew 28% YoY to INR 1,432 Cr; EBITDA up 33% at INR 313 Cr (22% margin); PAT up 27% at INR 228 Cr. CMD unveiled two new high-value products: indigenously developed Carbon Nanotube (200 MTPA, commissioning Q4FY27) and Super Speciality Carbon Black (6,000 MTPA). LFP cathode Phase 1 of 2,000 MTPA by Q3FY27, with 200,000 MTPA long-term plan backed by INR 4,800 Cr capex. Total two-year capex about INR 2,000 Cr, self-funded via free cash flow, no debt. INR 1,100 Cr PAT target by FY28 reiterated.

Likely market impact

Strong quarter with high-value product additions and self-funded capex roadmap; reiteration of FY28 PAT target and China-independent supply chain boosts confidence.